C.L. Lannon
Dalhousie University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C.L. Lannon.
Advances in Experimental Medicine and Biology | 1999
C.L. Lannon; Lynne M. Ball; Allen F. Pyesmany; Margaret Yhap; G. Ross Langley; Dick van Velzen
BACKGROUND High resolution Confocal Laser Scanning Microscopy (CLSM) may be applied to testing of drug resistance in vitro in clinical setting. Rapid analysis of DNA damage by precise quantitation of excised DNA in bone marrow samples exposed to potential treatment moieties directly after isolation but the relative sensitivity of the integrated method is as yet untested. AIMS To test the clinical applicability of SCGE/high resolution CLSM for differences in drug resistance in marrow cells. METHODS Cells from normal bone marrow samples were exposed for identical periods and at 4 concentrations to either 1 hour of standard Daunorubicin (.5, 1, 1.5, 2 micrograms/ml) or 8 hours DaunoXome (courtesy of NeXstar Inc, USA) (.05, .1, .15, .2 microgram/ml). After 2 and 6 hours recovery, cells were harvested for SCGE, randomization, analysis of tail length, total excised DNA and fragment size distribution using high resolution CLSM. RESULTS Tail length and fragment size distribution was not, but total excised DNA was significantly increased after 0.1 microgram/ml Liposomal Daunorubicin (DaunoXome) compared to 1.0 microgram/ml Daunorubicin. CONCLUSION SCGE/high resolution CLSM effectively demonstrated differences in Daunorubicin resistance of human marrow cells to alternative formulations. The method has potential for use in clinical testing of neoplastic cell drug resistance.
Advances in Experimental Medicine and Biology | 1999
Lynne M. Ball; C.L. Lannon; G. Ross Langley; Allen F. Pyesmany; Margaret Yhap; Dick van Velzen
BACKGROUND New analogues of DNA directed chemotherapy moieties are available for comparative efficacy testing in human neoplastic disease. In addition to MTT testing direct assessment of DNA excision repair activity after direct exposure of marrow cells may provide information on relative DNA effects in vitro. AIMS To assess the ability of SCGE/high resolution CLSM to detect differences in drug resistance between human neoplastic cell lines in the DNA excision repair response to chemotherapy. METHODS Eight human leukaemia samples (4 childhood, 4 adult) were exposed to 1 hour of single concentrations of daunorubicin, DaunoXome (courtesy NeXstar Pharmaceuticals Inc, USA), cyclophosphamide and 4-hydroperoxycyclophosphamide (4-HC, courtesy Dr. M. Colvin, Duke University, USA), followed by SCGE/high resolution CLSM with quantitation of total excised DNA. Differences between cases/drug moieties/exposures were analysed. RESULTS Although generally equal effect dose levels for DaunoXome were lower than for standard daunorubicin, patients/individual neoplastic cells differed considerably in optimal dose levels. Conventional cyclophosphamide in comparison to 4-HC showed inconsistent results indicating considerable differences in the level of drug resistance to the conventional product. CONCLUSIONS Direct testing for drug resistance patterns in DNA directed drug moieties by SCGE/CLSM reveals individual variability of human malignant cell lines warranting comparison with results of MTT testing and in-vivo patient response.
Advances in Experimental Medicine and Biology | 1999
C.L. Lannon; Lynne M. Ball; Allen F. Pyesmany; Margaret Yhap; Ross Langley; Dick van Velzen
BACKGROUND Assessment of resistance to drug moieties in tissue culture is complicated by limited sample, clonal selection and alteration of cycling fraction and cycle duration in clonally mixed lesions. DNA damage assessment by single cell gel electrophoresis (SCGE) of excised DNA is limited by non-linear analysis in fluorescent light microscopy. Confocal Laser Scanning Microscopy (CLSM) with high N.A. magnification allows for quantitation of total excised DNA fragment size distribution but is still limited by the large volume required for labour intensive SCGE, precluding multi-exposure clinical testing. AIMS To optimise sample requirement for SCGE and CLS. METHODS Standard slide mounted bed gels were punched with multiple coded 6 mm wells and filled with suspensions of cells subjected to drug/concentration variations. After SCGE, 30 microns frozen sections were prepared of each well and mounted in ethidium bromide solution on multi-well hydrophilic slides to allow for short working distance of high resolution CLSM in a Zeiss Axiovert L410 SM. Testing for feasibility, reproducibility and consistency used both cultured standard leukaemic cell lines, normal human control marrow and clinical samples. RESULTS AND CONCLUSION Multiple well SCGE followed by frozen section, high resolution CLSM allows for rapid analysis of high numbers of multiple drug exposure permutations clinically required.
Advances in Experimental Medicine and Biology | 1999
Lynne M. Ball; C.L. Lannon; Margaret Yhap; Allen F. Pyesmany; M. Henry; K. Laybolt; D. Christie Riddell; Dick van Velzen
International Journal of Toxicology | 1998
C.L. Lannon; S. A. Hinchliffe; J. D. Pope; Lynne M. Ball; D. van Velzen
Advances in Experimental Medicine and Biology | 1999
Lynne M. Ball; Allen F. Pyesmany; Margaret Yhap; C.L. Lannon; M. Henry; K. Laybolt; D. Christie Riddell; Dick van Velzen
European Journal of Cancer | 1997
Lynne M. Ball; C. Riddell; L. Resch; K. Laybolt; M. Henry; C.L. Lannon; J. Tam; D. van Velzen
European Journal of Cancer | 1997
Lynne M. Ball; C.L. Lannon; S. Murray; J. Tam; M. Henry; C. Isenor; A. MacKay; K. Laybolt; D. van Velzen
European Journal of Cancer | 1997
Lynne M. Ball; M. Henry; K. Laybolt; C.L. Lannon; S. Murray; A. MacKay; D. van Velzen
European Journal of Cancer | 1997
Lynne M. Ball; Allen F. Pyesmany; Margaret Yhap; K. Laybolt; M. Henry; J. Tam; C.L. Lannon; L. Resch; C. Riddell; D. van Velzen